New Veterans Bill Mandates GAO Audit of VA Menopause Care with 18-Month Deadline for Reform

The Improving Menopause Care for Veterans Act of 2025 sets a strict timeline for the Department of Veterans Affairs to modernize how it handles women’s health. Under Section 2, the Government Accountability Office (GAO) is required to launch a comprehensive study into the VA’s current medical services for perimenopause, menopause, and genitourinary syndrome of menopause. This isn't just a high-level check-in; the bill demands a deep dive into provider training, diagnostic protocols, and how often veterans are being referred to outside specialists when the VA can’t meet their needs. The GAO has exactly 18 months from the date of enactment to hand over a public report that details what’s working and what’s failing.

Mapping the Patient Experience

To make sure this study reflects real-world hurdles, the bill requires the GAO to evaluate "interdisciplinary care," which is policy-speak for whether a veteran can see all the specialists they need—like bone density experts or hormone specialists—without a bureaucratic runaround. For a veteran working a 9-to-5 or managing a household, this could eventually mean the difference between making five separate appointments and having a coordinated care plan. The report must also include direct feedback from veterans (Section 2(b)(5)) to assess if the VA has a functional way for patients to resolve complaints when their symptoms are dismissed or mistreated.

From Data to Action Plans

Once the report is public, the clock starts for the VA leadership. Within six months of the report’s release, the Secretary of the VA must submit a formal strategic plan to the House and Senate Veterans’ Affairs Committees. This plan acts as a roadmap for implementing the GAO’s recommendations and improving access to care under existing laws (specifically sections 1703 and 1710 of title 38). By tying the study to a mandatory implementation plan, the legislation aims to ensure the findings don't just sit on a shelf, but actually lead to updated training for doctors and better outreach so veterans know exactly what treatments—and risks—are available to them.